文献引用
-
1) Atraric acid increases the antitumor effect of BRAF inhibitor through the regulation of the HGK/MEK1/ERK signaling pathway.
-
2) Upregulation of PREX1 Expression by POU2F2 Promotes the Malignant Progression of Acute Myeloid Leukemia via the mTOR Pathway.
-
3) Electroacupuncture of Guanyuan (CV4) Acupoint Improved Pelvic Inflammatory Disease Pain by Inhibiting Neuroinflammation and Sympathetic Activity.
-
4) The potential of taVNS in attenuating blood-brain barrier damage, promoting angiogenesis and improving impaired cognitive function in a rat model of vascular cognitive impairment and dementia by activating the Wnt7/β-catenin signaling pathway.
-
5) Neferine reduces synovial inflammation and cardiac complications in a collagen-induced arthritis mouse model via inhibiting NF-κB/NLRP3 inflammasome axis.
-
6) Astragaloside IV Alleviates Cisplatin Chemotherapy-Induced Nephrotoxicity via Modulation of Nrf2/HO-1/NF-κB Pathway and Reversal of EMT Process.
-
7) Potential mechanisms of zinc sulfate in inhibiting porcine reproductive and respiratory syndrome virus replication: attenuation of oxidative stress, inflammatory response, and apoptosis.
-
8) PLK3-Activated Mitochondrial Apoptosis Pathway in the Pathogenesis of Sepsis-Associated Acute Kidney Injury.
-
9) LINC00885 promotes lung squamous cell carcinoma by upregulating SLBP expression to activate PI3K/Akt pathway.
-
10) D-Mannose Upregulates Testin via the NF-κB Pathway to Inhibit Breast Cancer Proliferation.
-
11) Natural Lignan Vitexin B-1 Induces Cell Cycle Arrest and Apoptosis via Targeting HSP90 Through EGFR Pathway in Non-Small Cell Lung Cancer.
-
12) Brucine Inhibits Gastric Cancer via Activation of Ferroptosis Through Regulating the NF-κB Signaling Pathway.
-
13) The NF-κB Signalling Regulates the Abnormal Functions of Neutrophils in Severe Periodontal Disease.
-
14) SMAD7-mediated ferroptosis in macrophages drives osteoporosis progression: A multi-omics study.
-
15) Effect of MicroRNA-4713-3p on Promoting Malignant Progression of Nasopharyngeal Carcinoma via Targeted Inhibition of EPHX3 to Activate Wnt/β-Catenin Signaling Pathway.